Quantcast

3 Stocks to Watch on Wednesday: Arrowhead Pharmaceuticals Inc (ARWR), VeriFone Systems Inc (PAY) and Streamline Health Solutions Inc. (STRM)


Shutterstock photo

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Defensive telecoms gained 2.6% on a positive day for U.S. equities, while treasury bonds were unchanged. The  S&P 500 Index gained 0.2%, the  Dow Jones Industrial Average surged 0.5% and the  Nasdaq Composite fell 0.2%.

3 Stocks to Watch on Wednesday: Arrowhead Pharmaceuticals Inc (ARWR), VeriFone Systems Inc (PAY) and Streamline Health Solutions Inc. (STRM) Several companies reported on their latest findings and quarterly results, including  Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ), VeriFone Systems Inc (NYSE: PAY ) and Streamline Health Solutions Inc. (NASDAQ: STRM ).

Here's what went down:

Arrowhead Pharmaceuticals Inc (ARWR)

Arrowhead Pharmaceuticals reported on its latest period late yesterday.

The company noted that its targeted RNAi Molecule platform, or TRiM, which uses ligand-mediated delivery and helps to enable tissue-specific targeting, has been a success.

Arrowhead Pharmaceuticals writes that the platform offers simplified manufacturing at a lower cost than before, as well as multiple ways of administrating the medication, including subcutaneous, intravenous and inhaled.

The company's second-generation subcutaneously-administered clinical candidate for the treatment of alpha-1 antitrypsin deficiency liver disease will have a trial during the first quarter of 2018.

ARWR stock fell 2.8% after hours Tuesday.

VeriFone Systems Inc (PAY)

VeriFone Systems reported on its latest quarter late Tuesday.

The company posted earnings of 44 cents per share during its fourth quarter of fiscal 2017, which topped Wall Street's consensus estimate of 43 cents per share. Revenue for the period was $477 million, beating out the consensus estimate of $472.46 million.

For fiscal 2018, VeriFone Systems projects that it will earn between $1.47 and $1.50 per share, compared to the Wall Street projection of $1.57 per share, according to its presser.

Revenue for the year is slated to be between $1.78 billion and $1.8 billion, while analysts are calling for revenue of $1.92 billion.

First-quarter earnings is expected to be 22 cents per share, below the guidance of 34 cents per share. Revenue is forecasted to be between $431 billion and $433 billion, while the consensus calls for $465.61 billion.

PAY stock fell 6.7% after the bell yesterday.

Streamline Health Solutions Inc. (STRM)

Streamline Health Solutions shares rose despite the company's revenue drop .

The company posted revenue of $6.4 million over the three-month period that ended October 31, 2017, which was 3% lower than revenue was during the year-ago quarter. The figure was 8% better quarter-to-quarter.

Net income came in at $3,000 for Streamline Health Solutions, compared to a net loss of $2 million during the same period a year ago. Earnings were $1.5 million on an adjusted basis, up from $0.2 million a year ago.

"Our third quarter financial performance improved from the second quarter primarily due to an increase in professional services and some recurring revenue as we experienced growth with existing clients in expanding the number of facilities utilizing our software," stated  David Sides , President and Chief Executive Officer, Streamline Health.

STRM stock surged 10.4% after hours.

As of this writing, Karl Utermohlen did not hold a position in any of the aforementioned securities.

More From InvestorPlace

The post 3 Stocks to Watch on Wednesday: Arrowhead Pharmaceuticals Inc (ARWR), VeriFone Systems Inc (PAY) and Streamline Health Solutions Inc. (STRM) appeared first on InvestorPlace .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Stocks
Referenced Symbols: ARWR , STRM



More from InvestorPlace Media

Subscribe






InvestorPlace Media
Contributor:

InvestorPlace Media

Investing, Financial News










Research Brokers before you trade

Want to trade FX?